Tuesday, September 27, 2022 | Back issues
Courthouse News Service Courthouse News Service

Pharma Merger

WILMINGTON, Del. - Directors are selling Dyax Corp. too cheaply through an unfair process to Shire Pharmaceuticals, for $37.30 a share or $5.9 billion, shareholders say in a class action in Delaware Chancery Court.

Read the Top 8

Sign up for the Top 8, a roundup of the day's top stories delivered directly to your inbox Monday through Friday.

Loading
Loading...